Phase II Multi-Center Study of T89 to Treat Chronic Stable Angina
Public ClinicalTrials.gov record NCT00797953. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Double Blind, Placebo-controlled, Randominzed, Multi-Center, Parallel Group Study to Evaluate the Efficacy and Safety of T89 in Patient With Chronic Stable Angina Pectoris
Study identification
- NCT ID
- NCT00797953
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Tasly Pharmaceuticals, Inc.
- Industry
- Enrollment
- 124 participants
Conditions and interventions
Conditions
Interventions
- T89 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2007
- Primary completion
- Nov 30, 2009
- Completion
- Dec 31, 2009
- Last update posted
- Dec 11, 2012
2007 – 2010
United States locations
- U.S. sites
- 15
- U.S. states
- 11
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Paradigm Clinical, Inc. | Tucson | Arizona | 85705 | — |
| Robert M. Karns, A Medical Corporation | Beverly Hills | California | 90211 | — |
| Inland Heart Doctors | Corona | California | 92879 | — |
| Sunrise Medical Research | Lauderdale Lakes | Florida | 33319 | — |
| Cardiovascular Research Center of South Florida | Miami | Florida | 33173 | — |
| Alexandria Cardiology Clinic | Alexandria | Louisiana | 71301 | — |
| Great Lakes Research Group, Inc | Bay City | Michigan | 48706 | — |
| Marc Kozinn Associates | Williamsville | New York | 14221 | — |
| Oklahoma Cardiovascular & Hypertension | Oklahoma City | Oklahoma | 73132 | — |
| Three Rivers Medical Associates | Columbia | South Carolina | 29201 | — |
| East Texas Cardiology | Houston | Texas | 77002 | — |
| Northwest Houston Cardiology | Houston | Texas | 77070 | — |
| Northwest Heart Center | Tomball | Texas | 77375 | — |
| National Clinical Research-Norfolk, Inc | Norfolk | Virginia | 23502 | — |
| Gemini Scientific, LLC | Madison | Wisconsin | 53719 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00797953, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 11, 2012 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00797953 live on ClinicalTrials.gov.